PATIENT INFORMATION

JOHN DOE

Age: 26 years
Date of Birth: 03/22/81
Location/ID: PRIVATE OFFICE

PHYSICIAN

JANE SMITH, M.D

1234 JANE WAY
HERCULES, CA 94547

CC: JACK SMITH M.D.

SPECIMEN INFORMATION

Accession # WCC-08-99999

Collected:02/12/2008
Received:02/12/2008
Reported:02/15/2008

HISTORY

MATURATION INDEX

SPECIMEN SOURCE: ANAL CYTOLOGY

Not applicable

ANAL CYTOLOGY TEST RESULTS BY ThinPrep®Date Reported: 2/15/2008

ATYPICAL squamous cells of undetermined significance, favor low-grade lesion (mild dysplasia and/or HPV effect). Suggest repeat anal cytology and/or tissue confirmation.

Pathologist: WAYNE L. GARRETT, D.O.

HUMAN PAPILLOMA VIRUS TEST RESULTS BY PCRDate Reported: 2/15/2008

HPVNegative
The sample is negative for the presence of HPV DNA. These results do not exclude the possibility of HPV not detected due to sampling or assay sensitivity.  This specimen tested negative for: LVX160, CP8061, CP6108, 6, 11, 16, 18, 26, 30, 31, 32, 33, 34, 35, 39, 42, 43, 44, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 72, 73, 74, 81, 82, 83, 84 and "Unknown." The presence of HPV in the anogenital tract is considered a precursor for the development of squamous epithelial dysplasia or neoplasia. Risk factors for dysplastic progression include infection with multiple HPV types and persistent, infection with high risk HPV types and an individual`s immune status.

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

HERPES SIMPLEX VIRUS DETECTION & GENOTYPING ASSAY BY PCRDate Reported: 2/14/2008

HSV, TYPE 1Not Detected
HSV, TYPE 2Positive
This sample is positive for evidence of DNA for Herpes Simplex Virus Type-2. There is no evidence of DNA for Herpes Simplex Virus Type-1.

Comment: These molecular genetic findings suggest the diagnosis of infection by Herpes Simplex Virus Type-2. Since there are potentially serious consequences of Herpes Simplex Virus Type-2 infection, current guidelines recommend the importance of testing the sexual partners of individuals positive for Herpes Simplex Virus Type-2 DNA, regardless of the presence or absence of clinical symptoms.

Special recommendations can be reviewed at http://www.cdc.gov/od/oc/media/pressrel/fs020509.htm and more comments are available at http://www.wcpl.com/dna_support_doc.asp

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

Note: For FDA comments, see http://www.wcpl.com/FDA.asp
712 Alfred Nobel Drive . Hercules, CA 94547 . toll free 800.794.9737 . fax 510.662.5240 . www.wcpl.com . John Compagno, M.D., Medical Director
PATHOLOGY/CYTOPATHOLOGY CONSULTATION REPORT